• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Centers for Disease Control and Prevention, Drugs (Pharmaceuticals), Elderly, Food and Drug Administration, GSK PLC, Guillain-Barre Syndrome, Pfizer Inc, Respiratory Syncytial Virus (RSV), Vaccination and Immunization, Viruses
←Amanda Gorman’s Book Sales Soar Amid Florida Bans Of Her Work
Conservatives Complain Chick-fil-A Has ‘Gone Woke’ Over D.E.I.→

More posts

  • Senate GOP Armed Services chair: ‘Time is over’ for talks with Iran

  • Ellen DeGeneres Returning To Voice Dory In New Short Out Of Pixar’s ‘Finding Nemo’ Universe

  • US imposes sanctions targeting Iran’s oil network in China

  • As Trump inspector general nominee waits in wings, Epstein files audit draws muted praise

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube